PDCD1 and neoplasm: Possible explanations would be that (1) PD-1 inhibitor enhances the activity of the tumor-infiltrating lymphocytes and promotes cytotoxic secretions for antitumor immune responses; thus, PD-1 inhibitor could exhibit a satisfying treatment efficacy (17).